CSL Vifor

Aug 26, 2023 | academic.oup.com | Baylor Scott |Muhammad Shahzeb |van Veldhuisen |CSL Vifor

See the editorial comment for this article ‘Intravenous iron repletion in heart failure: bridging the gap between symptom relief and hard clinical outcomes’, by H. Abu-Own et al., https://doi.org/10.1093/eurheartj/ehad746.

Aug 16, 2023 | academic.oup.com | Baylor Scott |CSL Vifor |Charité Universitätsmedizin Berlin

This commentary refers to ‘Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial’, by J. Butler et al., https://doi.org/10.1093/eurheartj/ehac401 and the discussion piece ‘Detailed safety analysis of DIAMOND trial: ‘primum non nocere’?’, by R. Baptista et al., https://doi.org/10.1093/eurheartj/ehad473.